SCRC, a real company with a real product. Below is

New Post Public Reply Private Reply Replies (2) Message Board
Guts
SCRC, a real company with a real product. Below is information found in Daily Med Publication reviewing Pediatric RapiMeds. Notice the article is revised March 2014. Pediatric RapiMeds is just one several revenue streams Mr. Schneiderman has developed which will drive SCRC's success.


The actual packaging does not copy here. Google "DEA and ScripsAmerica" to review for yourself.

http://dailymed.nlm.nih.gov/dailymed/lookup.c...5c8f6cba1f
JUNIOR STRENGTH PAIN AND FEVER RELIEF WILD CHERRY ( acetaminophen ) tablet, chewable
[ScripsAmerica]

Permanent Link:
http://dailymed.nlm.nih.gov/dailymed/lookup.c...5c8f6cba1f
Category
DEA Schedule
Marketing Status

HUMAN OTC DRUG LABEL OTC monograph not final
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Drug Label Sections
• Description
• Clinical Pharmacology
• Indications & Usage
• Contraindications
• Warnings
• Precautions
• Adverse Reactions
• Overdosage
• Dosage & Administration
• How Supplied
• Patient Counseling Information
• Supplemental Patient Material
• Boxed Warning
• Patient Package Insert
• Highlights
• Full Table of Contents
• Medication Guide
Active ingredient (in each tablet)
Acetaminophen 160 mg
Purpose
Pain reliever /fever reducer
Uses
? temporarily relieves minor aches and pains due to:
? the common cold
? flu
? headache
? temporarily reduces fever
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if your child takes:
? more than 5 doses in 24 hours, which is the maximum daily amount
? with other drugs containing acetaminophen
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting , consult a doctor promptly.
Do not use
? with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
? if your child is allergic to acetaminophen or any of the inactive ingredients in this product.
Ask a doctor before use if your child has
liver disease.
Ask a doctor or pharmacist before use if your child is
taking the blood thinning drug warfarin.
When using this product
do not exceed recommended dosage.
Stop use and ask a doctor if
? pain gets worse or lasts more than 5 days
? fever gets worse or lasts more than 3 days
? new symptoms occur
? redness or swelling is present
These could be signs of a serious condition.
Keep out of reach of children.
Overdose warning: Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. Quick medical attention is critical even if you do not notice any signs or symptoms.
Directions
? do not give more than directed
(see overdose warning)
? this product does not contain directions or complete warnings for adult use
? find the right dose on chart below. If possible, use weight to dose; otherwise, use age.
? dissolve in mouth or chew before swallowing
? if needed, repeat dose every 4 hours while symptoms last
? do not give more than 5 times in 24 hours
? do not give for more than 5 days unless directed by a doctor
Weight (lb) Age (yr) Tablets*
Under 48 Under 6 Ask a doctor
48-59 6-8 2
60-71 9-10 2 1/2
72-95 11 3
*or as directed by a doctor
Other information
? TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN
? store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F)
? avoid high humidity
? see end flap for expiration date and lot number
Inactive ingredients
citric acid, crospovidone, D&C red #27 aluminum lake, D&C red #30 aluminum lake, dextrose, ethylcellulose, flavors, magnesium stearate, mannitol, stearic acid, sucralose
Questions or comments?
Call 1-800-957-7622
Product Packaging
RapiMed™
Melts in Your Child"s Mouth
NDC 51208-003-24
Junior Strength
For Children Ages 6-11
Pain &
Fever Relief
ACETAMINOPHEN - 160 mg each
• Pain Reliever/Fever Reducer
• Contains no Aspirin
• Melts in Your Child's Mouth
24 Quick Dissolving Tablets
WILD CHERRY FLAVOR
50844 ORG111364408
Manufactured in the United States of America
Distributed by: Scrips America Inc.
Tyson Corner, VA 22102
Telephone: 1-800-596-4874
Website: www.rapidmeds.com
Email: wecare@rapidmeds.com
TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Scrips America 44-644
JUNIOR STRENGTH PAIN AND FEVER RELIEF WILD CHERRY
acetaminophen tablet, chewable
Product Information
Product Type HUMAN OTC DRUG LABEL Item Code (Source) NDC:51208-003
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 160 mg

Inactive Ingredients
Ingredient Name Strength
CITRIC ACID MONOHYDRATE
CROSPOVIDONE
D&C RED NO. 27
D&C RED NO. 30
DEXTROSE
ETHYLCELLULOSES
MAGNESIUM STEARATE
MANNITOL
STEARIC ACID
SUCRALOSE

Product Characteristics
Color PINK Score no score
Shape ROUND Size 16mm
Flavor BUBBLE GUM Imprint Code 44;644
Contains

Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:51208-003-24 1 in 1 CARTON
1 24 in 1 BLISTER PACK


Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC MONOGRAPH NOT FINAL part343 02/25/2005

Labeler - ScripsAmerica (842014177)
Establishment
Name Address ID/FEI Business Operations
LNK International, Inc. 038154464 PACK(51208-003)
Establishment
Name Address ID/FEI Business Operations
LNK International, Inc. 832867894 MANUFACTURE(51208-003)
Revised: 3/2014

ScripsAmerica
Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services

ScripsAmerica Inc (SCRC) Stock Research Links

SCRC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Babe Ruth Lots Lead Morphy's $2 Million Collectibles Auction

Updated Category News Views 39

Ruth still pulls money like few names ever will, and Morphy's November 10-12 auction made that plain without any circus tricks. Three lots tied to the Yankees legend produced $136,500 within a Toys, Sports & General Collectibles sale that topped $2 million. That is not some vague nostalgia story. Buyers put real dollars behind a 1932 U.S. Caramel card, a 1933 Goudey card,...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 25

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 158

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading
PayPal's New Leadership Map Puts Execution on Trial

Updated Category News Views 75

Four senior appointments and a risk-chief exit can turn a tidy strategy slide into a very real operating test. PayPal has spent months defining three-year plans, simplifying its operating model and assigning clearer accountability; on November 20, it put names beside the jobs. For NASDAQ:PYPL investors, that is more consequential than another broad promise about...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 32

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 23

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 17

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
SHEIN's EU Training Push Targets Seller Compliance Gaps

Updated Category News Views 72

Chemicals buried in a cheap handbag or kids' accessory can wreck a marketplace's credibility faster than any glossy campaign can repair it. That is the uncomfortable backdrop to SHEIN and SPEAC's November 19 session on EU chemical-safety rules for marketplace sellers. This was not a fashion trend webinar; it was a practical warning about high-risk substances, regulatory...

Continue Reading
Oman’s Dhofar II Wind Deal Clears Financing Hurdle

Updated Category News Views 111

Dhofar’s next wind farm has crossed the line that matters: financial close. That is less glamorous than turbines spinning against an Omani skyline, but it is the point where a project stops being an attractive deck and becomes a real contractual obligation. Sembcorp Utilities, alongside OQ Alternative Energy through Naseem Dhofar SAOC, has brought the 125-megawatt...

Continue Reading

Top 5 Most Recently Viewed Articles

Settlement Reached for Just Energy Shareholders Amid Controversy

Updated Category News Views 341

Class Action Settlement Overview Recently, a significant settlement agreement was reached by representatives of former shareholders involved in a class action against Just Energy Group Inc. This move is part of the legal proceedings initiated after the company's restatement of its financial statements in 2019. Shareholders have been keenly watching the developments in...

Continue Reading
Texas Southern University Launches Impactful Lawson Endowment

Updated Category News Views 419

New Endowment Established by Texas Southern University Texas Southern University (TSU) is excited to unveil the creation of the William A. Lawson Endowment, a scholarship initiative that pays tribute to the remarkable legacy of Rev. Dr. William A. Lawson, a highly respected figure in the civil rights movement and a guiding light within the community. This endowment is...

Continue Reading
Thailand's Air Conditioner Market: Growth and Innovation Ahead

Updated Category News Views 544

Understanding the Growth Trends in Thailand's Air Conditioner Market Thailand has experienced a significant boost in its air conditioner market, projected to reach a valuation of over US$ 2,937.83 million by 2033, an increase from US$ 1,721.28 million in 2024. This growth translates to an impressive compound annual growth rate (CAGR) of 6.12% from 2025 to 2033. Several...

Continue Reading
BiomX Achieves Milestones and Reports Q2 2025 Financials

Updated Category News Views 204

BiomX Reports Second Quarter Financial Results BiomX Inc. (NYSE American: PHGE), a clinical-stage biotechnology company focused on developing innovative phage therapies, has shared its financial results and clinical updates for the second quarter of 2025, showcasing pivotal advancements that underscore its position within the industry. Positive Clinical Developments...

Continue Reading
Celebrating Community Heroes: The PuroClean Superhero Initiative

Updated Category News Views 217

PuroClean Honors Local Leaders with Superhero Day Campaign The Paramedics of Property Damage Celebrate Community Heroes Nationwide PuroClean, a renowned leader in restoration and remediation franchises, has recently concluded its captivating National Superhero Day campaign. This initiative celebrated everyday heroes across communities who have dramatically impacted lives....

Continue Reading